更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。
米国
- 2024.11.11
- 2024.11.11
November 7, 2024
- Aminocaproic Acid Tablet (Discontinuation)
November 4, 2024
- Albuterol Sulfate Syrup (Discontinuation)
- Hydroxocobalamin Injection (Currently In Shortage)
- Ondansetron Hydrochloride Tablet (Discontinuation)
- 2024.11.04
- 2024.11.04
November 1, 2024
- Sodium Bicarbonate Injection (Currently In Shortage)
October 29, 2024
- Brexanolone Solution (Discontinuation)
- Somatropin Injection (Discontinuation)
October 28, 2024
- Exenatide Synthetic Injectable Suspension, Extended Release (Discontinuation)
October 25, 2024
- Exenatide Synthetic Injection (Discontinuation)
October 24, 2024
- Amoxapine Tablet (Currently In Shortage)
カナダ
カナダの情報はありません。
オーストラリア
- 2024.11.11
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Unavailable Manufacturing 8/11/2024 amlodipine besilate Tablet, uncoated 6.94 mg Anticipated Available Manufacturing 8/11/2024 midazolam Injection, solution 5 mg/mL Current Limited Availability Manufacturing 8/11/2024 sodium pyrophosphate Injection, powder for 30 mg Current Emergency Supply Only Manufacturing 8/11/2024 potassium clavulanate~amoxicillin trihydrate Suspension, powder for 7.45 mg/mL~28.7 mg/mL Current Unavailable Manufacturing 8/11/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Anticipated Available Manufacturing 8/11/2024 iopromide Injection, solution 498.72 mg/mL Resolved Available Unexpected increase in consumer demand 8/11/2024 hydrocortisone sodium succinate Injection, powder for 334.25 mg Resolved Available Manufacturing 8/11/2024 acetylcysteine Injection, concentrated 2 g Current Unavailable Transport / Logistic issues / Storage capacity issues 8/11/2024 diazepam Tablet, uncoated 2 mg Anticipated Available Manufacturing 8/11/2024 risperidone Tablet, film coated 2 mg Anticipated Available Unexpected increase in consumer demand 8/11/2024 zolmitriptan Tablet, film coated 2.5 mg Current Unavailable Manufacturing 8/11/2024 duloxetine hydrochloride Capsule, enteric 33.66 mg Current Unavailable Unexpected increase in consumer demand 8/11/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Current Unavailable Manufacturing 8/11/2024 meloxicam Capsule, hard 15 mg Resolved Available Manufacturing 8/11/2024 anastrozole Tablet, film coated 1 mg Current Limited Availability Manufacturing 8/11/2024 fluorouracil Injection, solution 50 mg/mL Current Limited Availability Manufacturing 8/11/2024 mesalazine Tablet, enteric coated 250 mg Anticipated Available Manufacturing 8/11/2024 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 8/11/2024 nebivolol hydrochloride Tablet 1.363 mg Current Limited Availability Manufacturing 8/11/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 8/11/2024 nebivolol hydrochloride Tablet 10.9 mg Resolved Available Manufacturing 8/11/2024 hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil Tablet, film coated 12.5 mg~6.95 mg~40 mg Resolved Available Manufacturing 8/11/2024 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 8/11/2024 lurasidone hydrochloride Tablet, film coated 80 mg Resolved Available Manufacturing 8/11/2024 lurasidone hydrochloride Tablet, film coated 40 mg Resolved Available Manufacturing 8/11/2024 lanreotide acetate Injection, solution 100 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 8/11/2024 lanreotide acetate Injection, solution 66.67 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 8/11/2024 daptomycin Inhalation, powder for 350 mg Current Limited Availability Manufacturing 8/11/2024 morphine sulfate pentahydrate Tablet, film coated 10 mg Discontinued Unavailable Commercial Changes / Commercial viability 8/11/2024 clindamycin phosphate Cream 22.8 mg/g Anticipated Available Transport / Logistic issues / Storage capacity issues 8/11/2024 clonazepam Tablet, uncoated .5 mg Current Limited Availability Manufacturing 8/11/2024 cabergoline Tablet, uncoated 2 mg Current Limited Availability Manufacturing 8/11/2024 baclofen Tablet, uncoated 25 mg Resolved Available Transport / Logistic issues / Storage capacity issues 8/11/2024 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Anticipated Available Manufacturing 7/11/2024 fluconazole Capsule, hard 200 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/11/2024 olanzapine Tablet, orally disintegrating 20 mg Anticipated Available Manufacturing 7/11/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Current Limited Availability Manufacturing 7/11/2024 tacrolimus monohydrate Capsule, hard 1.022 mg Anticipated Available Manufacturing 7/11/2024 bisoprolol fumarate Tablet 10 mg Current Unavailable Manufacturing 7/11/2024 levetiracetam Tablet, film coated 1000 mg Current Unavailable Manufacturing 7/11/2024 escitalopram oxalate Tablet, film coated 12.74 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 7/11/2024 escitalopram oxalate Tablet, film coated 25.47 mg Current Unavailable Manufacturing 7/11/2024 carboplatin Injection, solution 450 mg Anticipated Available Manufacturing 7/11/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 7/11/2024 simvastatin Tablet, film coated 20 mg Current Unavailable Manufacturing 7/11/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Limited Availability Manufacturing 7/11/2024 hydrochlorothiazide~irbesartan Tablet, film coated 12.5 mg~300 mg Anticipated Available Manufacturing 7/11/2024 cerliponase alfa Injection, solution 30 mg/mL Resolved Available Manufacturing 7/11/2024 dutasteride~tamsulosin hydrochloride Capsule, modified release 500 microgram~400 microgram Resolved Available Transport / Logistic issues / Storage capacity issues 7/11/2024 estradiol Drug delivery system, transdermal .39 mg Current Unavailable Manufacturing 7/11/2024 estradiol Drug delivery system, transdermal 1.56 mg Current Unavailable Manufacturing 7/11/2024 trimethoprim Tablet, uncoated 300 mg Current Limited Availability Manufacturing 7/11/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 7/11/2024 cefaclor monohydrate Oral Liquid, powder for 52.45 mg/mL Current Unavailable Unexpected increase in consumer demand 7/11/2024 potassium clavulanate~amoxicillin trihydrate Tablet, film coated 149 mg~574 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 7/11/2024 tirzepatide Injection, solution 7.5 mg Current Unavailable Commercial Changes / Commercial viability 7/11/2024 tirzepatide Injection, solution 12.5 mg Current Unavailable Commercial Changes / Commercial viability 7/11/2024 tirzepatide Injection, solution 10 mg Current Unavailable Commercial Changes / Commercial viability 7/11/2024 tirzepatide Injection, solution 2.5 mg Current Unavailable Commercial Changes / Commercial viability 7/11/2024 nizatidine Capsule 300 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 7/11/2024 clarithromycin Tablet, film coated 250 mg Current Limited Availability Unexpected increase in consumer demand 7/11/2024 fluticasone furoate Spray, suspension 27.5 microgram Anticipated Available Unexpected increase in consumer demand 6/11/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 6/11/2024 mycophenolate mofetil Tablet, film coated 500 mg Current Unavailable Manufacturing 6/11/2024 sildenafil citrate Tablet, film coated 28.1 mg Current Limited Availability Manufacturing 6/11/2024 mycophenolate mofetil Tablet, film coated 500 mg Resolved Available Manufacturing 6/11/2024 esomeprazole Capsule, enteric 40 mg Current Limited Availability Manufacturing 6/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 6/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 6/11/2024 atomoxetine hydrochloride Capsule, hard 91.2 mg Resolved Available Manufacturing 6/11/2024 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 6/11/2024 norethisterone acetate~estradiol~estradiol Drug delivery system, transdermal 2.7 mg~.78 mg~.62 mg Current Limited Availability Manufacturing 6/11/2024 norethisterone acetate~estradiol~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg~.78 mg Current Limited Availability Manufacturing 6/11/2024 estradiol Drug delivery system, transdermal .585 mg Current Unavailable Manufacturing 6/11/2024 estradiol Drug delivery system, transdermal .78 mg Current Unavailable Manufacturing 6/11/2024 estradiol Drug delivery system, transdermal 1.17 mg Current Unavailable Manufacturing 6/11/2024 chloramphenicol Eye Drops, solution 5 mg/mL Current Unavailable Manufacturing 6/11/2024 melatonin Capsule, hard 5 mg Current Limited Availability Unexpected increase in consumer demand 6/11/2024 estradiol~norethisterone acetate Drug delivery system, transdermal .62 mg~2.7 mg Current Unavailable Manufacturing 6/11/2024 norethisterone acetate~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg Current Limited Availability Manufacturing 6/11/2024 risperidone Tablet, film coated 4 mg Current Unavailable Manufacturing 5/11/2024 oxytocin Injection, solution 10 IU Current Unavailable Manufacturing 5/11/2024 progesterone Pessary, compressed 100 mg Current Unavailable Manufacturing 5/11/2024 citalopram hydrobromide Tablet, film coated 12.495 mg Anticipated Available Manufacturing 5/11/2024 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 5/11/2024 azithromycin dihydrate Tablet, film coated 524 mg Current Unavailable Manufacturing 5/11/2024 hydrochlorothiazide~irbesartan Tablet, film coated 25 mg~300 mg Anticipated Available Manufacturing 5/11/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Resolved Available Manufacturing 5/11/2024 tadalafil Tablet, film coated 10 mg Current Unavailable Manufacturing 5/11/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 5/11/2024 timolol maleate Eye Drops, solution 6.83 mg/mL Anticipated Available Commercial Changes / Commercial viability 5/11/2024 levothyroxine sodium Tablet 50 microgram Current Unavailable Manufacturing 5/11/2024 melatonin Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 5/11/2024 timolol maleate Eye Drops, solution 6.84 mg/mL Current Unavailable Manufacturing 5/11/2024 gefitinib Tablet, film coated 250 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 5/11/2024 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Current Unavailable Manufacturing 4/11/2024 morphine hydrochloride trihydrate Oral Liquid, solution 2 mg/mL Resolved Available Commercial Changes / Commercial viability 4/11/2024 morphine hydrochloride trihydrate Oral Liquid, solution 10 mg/mL Current Unavailable Commercial Changes / Commercial viability 4/11/2024 metformin hydrochloride Tablet, film coated 1000 mg Current Limited Availability Manufacturing 4/11/2024 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 4/11/2024 irbesartan Tablet, film coated 300 mg Current Unavailable Manufacturing 4/11/2024 pregabalin Capsule, hard 150 mg Anticipated Available Manufacturing 4/11/2024 quinagolide hydrochloride Tablet, uncoated .0819 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 4/11/2024 verapamil hydrochloride Tablet, modified release 180 mg Current Limited Availability Manufacturing 4/11/2024 morphine sulfate pentahydrate Capsule, modified release 90 mg Discontinued Unavailable Commercial Changes / Commercial viability 4/11/2024 clonidine hydrochloride Tablet, uncoated 150 microgram Current Limited Availability Manufacturing 4/11/2024 - 2024.11.04
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated primidone Tablet, uncoated 250 mg Current Limited Availability Manufacturing 1/11/2024 gentamicin Injection, solution 80 mg Current Limited Availability Manufacturing 1/11/2024 sodium pyrophosphate Injection, powder for 30 mg Current Emergency Supply Only Manufacturing 1/11/2024 Pancreatic extract Capsule, enteric 150 mg Resolved Available Unexpected increase in consumer demand 1/11/2024 silver sulfadiazine Cream 10 mg/g Current Unavailable Manufacturing 1/11/2024 hydrocortisone sodium succinate Injection, powder for 134 mg Resolved Available Manufacturing 1/11/2024 hydrocortisone sodium succinate Injection, powder for 334.25 mg Current Limited Availability Manufacturing 1/11/2024 levetiracetam Tablet, film coated 500 mg Anticipated Available Manufacturing 1/11/2024 ciprofloxacin hydrochloride Tablet, film coated 277.5 mg Current Unavailable Manufacturing 1/11/2024 ciprofloxacin hydrochloride Tablet, film coated 555 mg Current Limited Availability Manufacturing 1/11/2024 ciprofloxacin hydrochloride Tablet, film coated 832.5 mg Current Unavailable Manufacturing 1/11/2024 candesartan cilexetil Tablet, uncoated 4 mg Anticipated Available Manufacturing 1/11/2024 rizatriptan benzoate Tablet, orally disintegrating 14.53 mg Resolved Available Manufacturing 1/11/2024 tranexamic acid Injection, solution 1000 mg Current Limited Availability Commercial Changes / Commercial viability 1/11/2024 acarbose Tablet 100 mg Current Limited Availability Manufacturing 1/11/2024 acarbose Tablet 50 mg Current Unavailable Manufacturing 1/11/2024 acarbose Tablet 50 mg Current Unavailable Manufacturing 1/11/2024 cisatracurium besilate Injection, solution 14.07 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 1/11/2024 Follitropin alfa Injection, solution 75 IU Current Unavailable Manufacturing 1/11/2024 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 8 mg Current Limited Availability Manufacturing 1/11/2024 anastrozole Tablet, film coated 1 mg Anticipated Available Manufacturing 1/11/2024 cisplatin Injection, concentrated 1 mg/mL Current Unavailable Unexpected increase in consumer demand 1/11/2024 lacosamide Tablet, film coated 100 mg Resolved Available Commercial Changes / Commercial viability 1/11/2024 lacosamide Tablet, film coated 50 mg Resolved Available Manufacturing 1/11/2024 pregabalin Capsule, hard 150 mg Anticipated Available Manufacturing 1/11/2024 pregabalin Capsule, hard 25 mg Anticipated Available Manufacturing 1/11/2024 pregabalin Capsule, hard 75 mg Anticipated Available Manufacturing 1/11/2024 montelukast sodium Tablet, film coated 10.4 mg Resolved Available Manufacturing 1/11/2024 norethisterone acetate~estradiol~estradiol Drug delivery system, transdermal 4.8 mg~.512 mg~.78 mg Current Limited Availability Manufacturing 1/11/2024 estradiol Drug delivery system, transdermal .585 mg Current Unavailable Manufacturing 1/11/2024 estradiol Drug delivery system, transdermal 1.56 mg Current Unavailable Manufacturing 1/11/2024 mycophenolate sodium Tablet, enteric coated 384.7 mg Anticipated Available Manufacturing 1/11/2024 phentermine hydrochloride Tablet, modified release 49.7 mg Current Limited Availability Manufacturing 1/11/2024 flecainide acetate Tablet 50 mg Current Unavailable Manufacturing 1/11/2024 carmustine Injection, powder for 100 mg Current Limited Availability Manufacturing 1/11/2024 cefaclor monohydrate Oral Liquid, powder for 52.45 mg/mL Current Unavailable Unexpected increase in consumer demand 1/11/2024 cisplatin Injection, solution 1 mg/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 1/11/2024 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Current Unavailable Manufacturing 1/11/2024 estradiol hemihydrate Drug delivery system, transdermal 2.32 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 1/11/2024 oxycodone hydrochloride Oral Liquid, solution 1 mg/mL Current Limited Availability Unexpected increase in consumer demand 1/11/2024 pravastatin sodium Tablet, uncoated 40 mg Current Unavailable Manufacturing 1/11/2024 terbinafine hydrochloride Tablet, uncoated 281.3 mg Anticipated Available Manufacturing 31/10/2024 metformin hydrochloride Tablet, film coated 500 mg Current Unavailable Manufacturing 31/10/2024 gabapentin Tablet, film coated 600 mg Anticipated Available Manufacturing 31/10/2024 doxorubicin hydrochloride Injection, concentrated 2 mg/mL Anticipated Available Manufacturing 31/10/2024 montelukast sodium Tablet, chewable 4.16 mg Anticipated Available Manufacturing 31/10/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Limited Availability Manufacturing 31/10/2024 duloxetine hydrochloride Capsule, enteric 33.65 mg Current Unavailable Manufacturing 31/10/2024 rizatriptan benzoate Wafer 14.53 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 31/10/2024 meloxicam Capsule, hard 15 mg Current Unavailable Manufacturing 31/10/2024 azacitidine Injection, powder for 100 mg Resolved Available Manufacturing 31/10/2024 rasagiline mesilate Tablet 1.56 mg Current Limited Availability Manufacturing 31/10/2024 bortezomib Injection, solution 3.5 mg Resolved Available Manufacturing 31/10/2024 sitagliptin hydrochloride monohydrate~metformin hydrochloride Tablet, modified release 56.685 mg~1000 mg Current Unavailable Manufacturing 31/10/2024 thiotepa Injection, powder for 15 mg Current Unavailable Commercial Changes / Commercial viability 31/10/2024 clindamycin phosphate Cream 22.8 mg/g Anticipated Available Transport / Logistic issues / Storage capacity issues 31/10/2024 tobramycin Inhalation, conventional 60 mg/mL Current Unavailable Manufacturing 31/10/2024 clarithromycin Tablet, film coated 250 mg Current Limited Availability Manufacturing 31/10/2024 methylphenidate hydrochloride Tablet, modified release 18 mg Current Limited Availability Manufacturing 31/10/2024 morphine sulfate pentahydrate Tablet, modified release 60 mg Current Unavailable Manufacturing 30/10/2024 potassium clavulanate~amoxicillin trihydrate Suspension, powder for 7.45 mg/mL~28.7 mg/mL Current Unavailable Manufacturing 30/10/2024 metoprolol succinate Tablet, modified release 190 mg Current Unavailable Manufacturing 30/10/2024 galantamine hydrobromide Capsule, modified release 30.756 mg Current Limited Availability Manufacturing 30/10/2024 azithromycin dihydrate Tablet, film coated 524.05 mg Current Limited Availability Manufacturing 30/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 30/10/2024 cefepime hydrochloride monohydrate Injection, powder for 2378.5 mg Discontinued Unavailable Manufacturing 30/10/2024 cefepime hydrochloride monohydrate Injection, powder for 1189.2 mg Discontinued Unavailable Manufacturing 30/10/2024 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Manufacturing 30/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 30/10/2024 tadalafil Tablet, film coated 10 mg Anticipated Available Manufacturing 30/10/2024 nebivolol hydrochloride Tablet 5.45 mg Current Limited Availability Manufacturing 30/10/2024 tadalafil Tablet, film coated 20 mg Current Limited Availability Manufacturing 30/10/2024 dasatinib Tablet, film coated 50 mg Current Unavailable Manufacturing 30/10/2024 dasatinib Tablet, film coated 100 mg Current Unavailable Manufacturing 30/10/2024 dasatinib Tablet, film coated 70 mg Current Unavailable Commercial Changes / Commercial viability 30/10/2024 atomoxetine hydrochloride Capsule, hard 45.5 mg Resolved Available Manufacturing 30/10/2024 gefitinib Tablet, film coated 250 mg Current Unavailable Manufacturing 30/10/2024 tamsulosin hydrochloride~dutasteride Capsule, modified release 400 microgram~500 microgram Current Limited Availability Transport / Logistic issues / Storage capacity issues 30/10/2024 olanzapine Tablet, uncoated 2.5 mg Anticipated Available Manufacturing 30/10/2024 dasatinib propylene glycol Tablet, film coated 58 mg Current Unavailable Manufacturing 30/10/2024 dasatinib propylene glycol Tablet, film coated 23.2 mg Discontinued Unavailable Manufacturing 30/10/2024 carbachol Injection, solution 100 microgram/mL Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 30/10/2024 octreotide Injection, solution 50 microgram/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 30/10/2024 clarithromycin Oral Liquid, powder for 50 mg/mL Current Limited Availability Unexpected increase in consumer demand 30/10/2024 Mycobacterium bovis (Bacillus Calmette and Guerin (BCG) strain) Injection, powder for 200000000 CFU Current Limited Availability Unexpected increase in consumer demand 30/10/2024 clindamycin hydrochloride Solution 10 mg/mL Resolved Available Manufacturing 30/10/2024 prazosin hydrochloride Tablet, uncoated 1.1 mg Current Unavailable Manufacturing 30/10/2024 prazosin hydrochloride Tablet, uncoated 2.2 mg Current Unavailable Manufacturing 30/10/2024 prazosin hydrochloride Tablet, uncoated 5.5 mg Current Unavailable Manufacturing 30/10/2024 morphine sulfate pentahydrate Tablet, modified release 10 mg Current Unavailable Manufacturing 29/10/2024 morphine sulfate pentahydrate Tablet, modified release 30 mg Current Unavailable Manufacturing 29/10/2024 levetiracetam Tablet, film coated 250 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 29/10/2024 metoprolol succinate Tablet, modified release 95 mg Current Unavailable Manufacturing 29/10/2024 zolmitriptan Tablet, film coated 2.5 mg Anticipated Available Manufacturing 29/10/2024 Digoxinspecific antibody fragment F(ab) (Ovine) Injection, powder for 40 mg Resolved Available Manufacturing 29/10/2024 metformin hydrochloride Tablet, modified release 1000 mg Resolved Available Manufacturing 29/10/2024 pemetrexed disodium Injection, powder for 1102.9 mg Resolved Available Manufacturing 29/10/2024 ezetimibe Tablet, uncoated 10 mg Resolved Available Manufacturing 29/10/2024 fluticasone propionate Inhalation, pressurised 125 microgram/actuation Resolved Available Manufacturing 29/10/2024 tenofovir disoproxil fumarate~emtricitabine Tablet, film coated 300 mg~200 mg Current Limited Availability Manufacturing 29/10/2024 metformin hydrochloride Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 29/10/2024 tadalafil Tablet, film coated 5 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 29/10/2024 tadalafil Tablet, film coated 20 mg Resolved Available Unexpected increase in consumer demand 29/10/2024 olmesartan medoxomil~amlodipine besilate Tablet, film coated 40 mg~6.935 mg Resolved Available Manufacturing 29/10/2024 prasugrel Tablet, film coated 10 mg Current Limited Availability Manufacturing 29/10/2024 indometacin Capsule, hard 25 mg Resolved Available Manufacturing 29/10/2024 melatonin Capsule, hard 5 mg Anticipated Available Unexpected increase in consumer demand 29/10/2024 melatonin Oral Liquid, solution 1 mg/mL Anticipated Available Unexpected increase in consumer demand 29/10/2024 iopromide Injection, solution 498.72 mg/mL Resolved Available Unexpected increase in consumer demand 29/10/2024 diclofenac sodium Suppository, moulded 50 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 29/10/2024 clarithromycin Tablet, film coated 250 mg Resolved Available Manufacturing 28/10/2024 morphine sulfate pentahydrate Tablet, modified release 100 mg Current Unavailable Manufacturing 28/10/2024 sodium polystyrene sulfonate Powder 999.3 mg/g Anticipated Available Manufacturing 28/10/2024 acetylcysteine Injection, concentrated 2 g Current Limited Availability Transport / Logistic issues / Storage capacity issues 28/10/2024 Hepatitis a virus antigen Injection, suspension 320 AgU/mL Resolved Available Manufacturing 28/10/2024 metoprolol succinate Tablet, modified release 190 mg Anticipated Available Manufacturing 28/10/2024 midazolam Injection, solution 1 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 28/10/2024 ziprasidone hydrochloride Capsule, hard 65.16 mg Resolved Available Transport / Logistic issues / Storage capacity issues 28/10/2024 chromium(51Cr) edetate Injection, solution 8 MBq/mL Resolved Available Manufacturing 28/10/2024 esomeprazole Capsule, enteric 40 mg Anticipated Available Manufacturing 28/10/2024 nebivolol hydrochloride Tablet 10.9 mg Resolved Available Manufacturing 28/10/2024 lanreotide acetate Injection, solution 133.33 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 28/10/2024 oxycodone hydrochloride Capsule, hard 10 mg Resolved Available Commercial Changes / Commercial viability 28/10/2024 morphine sulfate pentahydrate Capsule, modified release 60 mg Discontinued Unavailable Commercial Changes / Commercial viability 28/10/2024 pamidronate disodium Injection, concentrated 3 mg Resolved Available Manufacturing 28/10/2024 pamidronate disodium Injection, concentrated 6 mg Resolved Available Manufacturing 28/10/2024
ドイツ
- 2024.11.11
Active ingredients Message type Type of reason Date of the last message Eletriptan hydrobromide Change notification Other 08.11.2024 Terazosin hydrochloride dihydrate Initial notification Other 08.11.2024 Cinacalcethydrochloride Change notification Other 08.11.2024 Paricalcitol Change notification Other 08.11.2024 Vinblastine sulfate Change notification Production problem 08.11.2024 Sodium thiosulphate (Ph.Eur.) Change notification Other 07.11.2024 Sodium thiosulphate (Ph.Eur.) Initial notification Other 07.11.2024 Metronidazole Change notification Other 06.11.2024 Fosfomycin sodium (Ph.Eur.) Initial notification Production problem 06.11.2024 Atenolol; chlorthalidone Change notification Other 06.11.2024 Insulin aspart Change notification Other 06.11.2024 Buprenorphine hydrochloride Change notification Production problem 06.11.2024 Clobetasol propionate (Ph.Eur.) Change notification Other 06.11.2024 Lanthanum(III) carbonate x H<2>O Change notification Other 06.11.2024 Haloperidol decanoate Initial notification Production problem 06.11.2024 Carbamazepine Change notification Production problem 05.11.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Change notification Production problem 05.11.2024 Phenoxymethylpenicillin potassium Change notification Other 05.11.2024 Carboplatin Change notification Other 05.11.2024 Cefadroxil monohydrate Change notification Other 05.11.2024 Amoxicillin trihydrate Change notification Other 05.11.2024 Oxcarbazepine Change notification Other 05.11.2024 Azithromycin dihydrate Change notification Other 05.11.2024 Ethosuximide Change notification Other 05.11.2024 Candesartancilexetil Change notification Other 05.11.2024 Alprostadil Change notification Other 05.11.2024 Levetiracetam Initial notification Other 05.11.2024 Oxazepam Initial notification Other 05.11.2024 Dexamethasone Initial notification Other 05.11.2024 Insulin aspart Change notification Other 05.11.2024 Azithromycin dihydrate Change notification Other 05.11.2024 Hydromorphone hydrochloride Change notification Other 05.11.2024 Azithromycin dihydrate Change notification Other 05.11.2024 Phenoxymethylpenicillin potassium Change notification Production problem 05.11.2024 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Change notification Other 05.11.2024 Azithromycin dihydrate Change notification Other 05.11.2024 Minocycline hydrochloride ((anhydrous, not pharmacopoeia compliant)) Change notification Other 05.11.2024 Mesalazine Change notification Other 04.11.2024 Phenytoin Initial notification Other 04.11.2024 Timolol maleate Change notification Production problem 04.11.2024 Phenylephrine hydrochloride Initial notification Production problem 04.11.2024 Darifenacin hydrobromide Initial notification Other 04.11.2024 Acemetacin Change notification Production problem 04.11.2024 - 2024.11.04
Active ingredients Date of the last message Type of reason Type of notification Erythromycin estolate 01.11.2024 Other Initial notification Poly(styrene-co-divinylbenzene)sulfonic acid-(x:y)-((81)Rb)rubidium salt 01.11.2024 Other Change notification Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) 01.11.2024 Other Change notification Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) 01.11.2024 Other Change notification Acetylcholine chloride 01.11.2024 Production problem Initial notification Prednisolone acetate 01.11.2024 Production problem Initial notification Hydromorphone hydrochloride 01.11.2024 Production problem Change notification Doxorubicin hydrochloride 31.10.2024 Production problem Initial notification Hydromorphone hydrochloride 31.10.2024 Other Initial notification Oxycodone hydrochloride (Ph.Eur.) 31.10.2024 Other Change notification Clarithromycin 31.10.2024 Other Change notification Oxazepam 31.10.2024 Other Initial notification Oxazepam 31.10.2024 Other Initial notification Clioquinol; flumetasone pivalate (Ph.Eur.) 31.10.2024 Other Change notification Insulin aspart 31.10.2024 Other Change notification Glucagon 30.10.2024 Production problem Initial notification Azithromycin dihydrate 30.10.2024 Other Change notification Buprenorphine hydrochloride 30.10.2024 Production problem Change notification Salbutamol sulfate 29.10.2024 Other Change notification Phenoxymethylpenicillin potassium 29.10.2024 Other Change notification Amoxicillin trihydrate 29.10.2024 Other Change notification Doxycycline monohydrate 29.10.2024 Other Change notification Doxycycline monohydrate 29.10.2024 Other Change notification Azithromycin dihydrate 29.10.2024 Other Change report Sodium valproate; valproic acid 29.10.2024 Other Change report Medroxyprogesterone acetate 29.10.2024 Other Change report Clarithromycin 29.10.2024 Other Change report Azacitidine 29.10.2024 Other Change report Paricalcitol 29.10.2024 Other Change report Oxcarbazepine 29.10.2024 Other Change report Atomoxetine hydrochloride 29.10.2024 Production problem Change report Atomoxetine hydrochloride 29.10.2024 Production problem Change report Atomoxetine hydrochloride 29.10.2024 Production problem Change report Atomoxetine hydrochloride 29.10.2024 Production problem Change report Atomoxetine hydrochloride 29.10.2024 Production problem Change report Atomoxetine hydrochloride 29.10.2024 Production problem Change report Atomoxetine hydrochloride 29.10.2024 Production problem Initial report Olanzapine embonate monohydrate 29.10.2024 Production problem Change report Hydromorphone hydrochloride 29.10.2024 Other Change report Ethosuximide 29.10.2024 Other Initial report Hydrocortisone 29.10.2024 Other Change report Benzyl benzoate 29.10.2024 Production problem Change report Salbutamol sulfate 29.10.2024 Other Change report Dexamethasone; gentamicin sulphate 29.10.2024 Production problem Change report Mesalazine 28.10.2024 Other Change report Remifentanil hydrochloride 28.10.2024 Other Initial report Dutasteride; tamsulosin hydrochloride 28.10.2024 Other Change report Risperidone 28.10.2024 Production problem Change report Vinblastine sulfate 28.10.2024 Production problem initial report Ezetimibe 28.10.2024 Other initial report
フランス
- 2024.11.11
Status Update Specialty Availability Nov. 8, 2024 Depakine Chrono 500 mg, extended-release scored film-coated tablet – [sodium valproate] Supply tension Nov. 8, 2024 Lantus Solostar 100 units/ ml, solution for injection in pre-filled pen – [insulin glargine]. Availability Nov. 8, 2024 Fasturtec 1.5 mg/ml, powder and solvent for solution to be diluted for infusion 1 ml glass ampoule – [rasburicase] Supply tension Nov. 8, 2024 Sinemet 250 mg/25 mg, scored tablet – [levodopa – carbidopa] Supply tension Nov. 8, 2024 Sinemet 100 mg/10 mg, tablet – [levodopa – carbidopa] [levodopa – carbidopa] [levodopa – carbidopa] [levodopa – carbidopa Out of stock Nov. 8, 2024 Etoposide Accord 20 mg/ml, dilutable solution for infusion – [etoposide] Supply tension Nov. 7, 2024 Cyanokit 5 g, powder for solution for infusion – [hydroxocobalamin] Out of stock Nov. 7, 2024 Marsilid 50 mg, scored tablet – [iproniazide] Supply tension Nov. 7, 2024 Vitamin B12 Gerda 1000 µg/4 ml, solution for injection (IM) and oral use – [cyanocobalamine] Supply tension Nov. 7, 2024 Vitamin B12 Delagrange 1000 micrograms/2 ml, solution for injection (IM) and oral use – [cyanocobalamin] Supply tension Nov. 7, 2024 Fluorouracil Teva 50 mg/ml, dilutable solution for infusion, 100 ml bottle – [fluorouracil] Out of stock Nov. 6, 2024 Zophren 2 mg/ml, solution for injection in ampoule (IV) (box 1 ampoule of 4 ml) – [ondansetron]. Supply tension Nov. 5, 2024 Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringe – [peginterferon alfa-2a]. Out of stock Nov. 5, 2024 Potassium citrate AP-HP 1 g, sachet of 100 capsules – [potassium citrate] Availability Nov. 5, 2024 Abacavir, Lamivudine, Zidovudine Viatris 300 mg/150 mg/300 mg, film-coated tablet – [abacavir (sulfate d’), lamivudine, zidovudine] Out of stock 5-Nov-24 Icatibant Viatris 30 mg, solution for injection in pre-filled syringe – [icatibant (acetate) Supply tension Nov. 4, 2024 Normal human immunoglobulin IV and SC (based on) – [Normal human immunoglobulin (IgG)]. Supply tension Nov. 4, 2024 Concerta LP, extended-release tablet – [methylphenidate (hydrochloride) Marketing discontinuation Nov. 4, 2024 Tsoludose, oral solution in unidose container – [levothyroxine] Supply tension Nov. 4, 2024 Furosemide Zentiva 500 mg, scored tablet – [furosemide] Supply tension Nov. 4, 2024 Methylphenidate Biogaran LP, extended-release tablet – [methylphenidate (hydrochloride) - 2024.11.04
Status Update Specialty End of commercialization Oct. 31, 2024 Ribarivine Biogaran 200 mg/400 mg, film-coated tablet – [Ribavirin] Supply tension Oct. 31, 2024 Ultratechnekow FM, 2.15 – 43 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de) Supply voltage Oct. 31, 2024 Tekcis 2-50 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de) Release Oct. 31, 2024 Hydrocortisone Upjohn 500 mg, injectable preparation – [hydrocortisone (sodium hydrogen succinate)] Supply tension Oct. 30, 2024 Gardenal 200 mg/4 ml, powder and solvent for solution for injection – [phenobarbital sodium]. Supply tension Oct. 30, 2024 Immunoglobulin normal human IV and SC (based on) – [Immunoglobulin normal human (IgG) Availability Oct. 29, 2024 NovoEight 3000 IU powder and solvent for injectable solution – [turoctocog alfa] Out of stock Oct. 29, 2024 Kanokad 25 IU/mL factor IX, powder and solvent for solution for injection – Vials of 250 IU (10 ml) and 500 IU (20 ml) Supply tension Oct. 28, 2024 Ritalin LP 40 mg, sustained-release capsule – [methylphenidate (hydrochloride) Availability Oct. 28, 2024 Ritalin LP 20 mg and 30 mg, extended-release capsule – [methylphenidate (hydrochloride)] Supply tension Oct. 25, 2024 Cynomel 0.025 mg, scored tablets- [liothyronine sodium]. Marketing discontinuation Oct. 25, 2024 Heparin Choay 25 000 IU/5 ml, solution for injection, 1 glass vial(s) of 5 ml – [heparin sodium].
英国
- 2024.11.06
モリブデン-99/テクネチウム-99m発電機の不足管理 (最終更新日:2024年10月29日) 更新： 英国核医学会からの手紙の最新版へのリンク。
更新：環境庁のセクションが追加されました
利用可能な膵臓酵素補充療法の処方と注文 (最終更新日:2024年10月29日)
更新： Nutrizym の使用に関する注意が追加されました。Pancrex製品の入手可能性に変更しました。
ADHDの薬不足に対応した支援体制について (更新日:2024年11月1日)
更新： 不足期間中のメチルフェニデートの使用に関するガイダンスを修正しました。
放出性メチルフェニデートの処方と切り替え(最終更新日:2024年11月1日)
更新：アドバイスを明確にするためにページを完全に更新し、タイトルを「ADHDの薬不足の継続的な管理」から変更しました。
ADHDの治療薬の処方(最終更新日:2024年11月1日)
更新： リタリンXL徐放性カプセルは現在、英国で販売されています。
EU
EUの情報はありません。